The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to fight respiratory viruses like COVID-19 and the flu.

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

President Trump’s announcement of new tariffs on semiconductors and pharmaceuticals kept markets in flux. Plus: Drugmaker Pfizer boosted its annual profit guidance. And, data-software company Palantir ...

NEW YORK: Wall Street stocks retreated Tuesday as markets monitored ongoing trade talks ahead of new tariff hikes set to take ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...